What is the rotigotine transdermal patch equivalent for a Dotti patch delivering 0.05 mg per 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Dotti 0.05 mg/24 hour Transdermal Patch Equivalent

There is no rotigotine transdermal patch equivalent for Dotti 0.05 mg/24 hour because Dotti is an estradiol patch, not a dopamine agonist. These are completely different medications used for entirely different indications.

Understanding the Confusion

Dotti is an estradiol transdermal system used for hormone replacement therapy in postmenopausal women 1. The available strengths are:

  • 0.025 mg/day
  • 0.0375 mg/day
  • 0.05 mg/day
  • 0.075 mg/day
  • 0.1 mg/day

Rotigotine is a dopamine agonist transdermal patch used for Parkinson's disease and restless legs syndrome 2, 3, 4. These are fundamentally different drug classes with no interchangeability.

Clinical Context

If You Need Estradiol Replacement:

  • Dotti 0.05 mg/24 hour delivers estradiol for menopausal symptoms, vulvar/vaginal atrophy, or osteoporosis prevention 1
  • Apply twice weekly to trunk (abdomen or buttocks), not breasts 1
  • Other estradiol patches may be equivalent, but rotigotine is not

If You Need Dopamine Agonist Therapy:

  • Rotigotine patches come in 1,2,3,4,6, and 8 mg/24 hour strengths 3, 4
  • Used for Parkinson's disease motor symptoms and non-motor symptoms 5
  • Applied once daily with different dosing than estradiol

Key Takeaway

You cannot substitute rotigotine for Dotti or vice versa. If you're looking for an alternative estradiol patch to Dotti 0.05 mg/24 hour, consult other estradiol transdermal products with the same dose. If you need a dopamine agonist, rotigotine is a separate consideration entirely unrelated to estradiol therapy.

References

Related Questions

Does rotigotine (Neupro) or piribedil (Clarium) have a higher risk of fatigue?
Should I increase my Requip (ropinirole) dose or try a different medication, such as pramipexole or rotigotine, since Requip is losing its effectiveness?
What is the recommended regimen for adding rotigotine to levodopa/carbidopa therapy in an adult with Parkinson’s disease?
What is the percentage of augmentation associated with the rotigotine transdermal patch (Neupro®), oral rotigotine, and oral pramipexole?
For a 35-year-old woman with hypertension (blood pressure 167/87 mm Hg), who smokes cigarettes and uses marijuana, has irregular menstrual periods, and needs a refill of depot medroxyprogesterone acetate (DMPA) injection, what is the appropriate contraceptive management?
Should a patient with a first-degree relative who had breast cancer undergo mammographic screening?
A patient has been taking Contrave (naltrexone 8 mg/bupropion 90 mg) for 8 weeks and reports that the appetite‑suppressing effect has diminished; is this expected?
Can Metamucil (psyllium husk) improve diarrhea in an adult with normal renal and cardiac function?
In a patient with concurrent iron deficiency and vitamin B12 deficiency, what underlying conditions should be suspected?
What is the workup for iron deficiency and low ferritin in a 20-year-old male cross-country runner?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.